Patrick Kennedy

CIK: 0002013944

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (60.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

JAZZ

Jazz Pharmaceuticals plc

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

JAZZ
Jazz Pharmaceuticals plc
Aug 31, 2026
Tax Payment(F)
Direct
15 shares at avg. $244.06$4K
JAZZ
Jazz Pharmaceuticals plc
Aug 31, 2026
Tax Payment(F)
Direct
1.8K shares at avg. $241.39$444K
JAZZ
Jazz Pharmaceuticals plc
Aug 5, 2026
Award(A)
Direct
1.6K shares-
JAZZ
Jazz Pharmaceuticals plc
Aug 8, 2025
Tax Payment(F)
Direct
2K shares at avg. $111.25$218K
JAZZ
Jazz Pharmaceuticals plc
Aug 7, 2025
Award(A)
Direct
3.5K shares-

		Type	Shares	Price		Ownership
Aug 31, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	15	$244.06	$3,661	Direct
Aug 31, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	1,840	$241.39	$444,158	Direct
Aug 5, 2026	JAZZ Jazz Pharmaceuticals plc	Award(A)	1,605	-	$0	Direct
Aug 8, 2025	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	1,959	$111.25	$217,940	Direct
Aug 7, 2025	JAZZ Jazz Pharmaceuticals plc	Award(A)	3,507	-	-	Direct

1-5 of 5 transactions

About Kennedy Patrick

Kennedy Patrick (SEC CIK 0002013944) files insider reports with the SEC as Director of Jazz Pharmaceuticals plc (JAZZ).

Signal8 holds 3 ownership filings by Kennedy Patrick, all Form 4s, filed between Aug 11, 2025 and Sep 2, 2026. Those filings report 5 transactions, from Aug 7, 2025 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kennedy Patrick's filings is in DUBLIN 4.

Recent filings by Kennedy Patrick

Aug 31, 2026: Tax withholdings of JAZZ shares (2 lines, Form 4, code F).
Aug 5, 2026: Grant or award of JAZZ shares (Form 4, code A).
Aug 8, 2025: Tax withholding of JAZZ shares (Form 4, code F).
Aug 7, 2025: Grant or award of JAZZ shares (Form 4, code A).

Other insiders filing for Jazz Pharmaceuticals plc (JAZZ)

GALA RENEE D, President & CEO
COZADD BRUCE C, Director
Patil Neena M, EVP & Chief Legal Officer
Henderson Mary Elizabeth, SVP, Technical Operations
Smith Mark Douglas, Director
RIEDEL NORBERT G, Director

How to read Form 4 transaction codes